Skip to main content

Advertisement

Table 2 Cytokine levels in each patient group

From: An increase in mean platelet volume after admission is associated with higher mortality in critically ill patients

Cytokine (pg/mL), median (IQ) ΔPlat24h ≤ 0 ΔPlat24h ≥ 0  
ΔMPV24h ≤ 0 ΔMPV24h ≥ 0 ΔMPV24h ≤ 0 ΔMPV24h ≥ 0 P-value
IL1β 2.14 (1.49;3.91) 2.07 (1.49;4.23) 1.84 (0.95;5.45) 2.13 (1.22;3.19) 0.793
IL6 37.33 (10.44;80.23) 57.43 (17.64;404.0) 25.98 (10.77;55.93) 40.08 (10.34;96.83) 0.187
IL8 32.00 (19.52;58.75) 57.14 (22.34;134.20) 24.42 (8.71;65.96) 40.13 (30.18;54.41) 0.174
IL10 19.4 (6.89;44.03) 38.41 (9.41;79.47) 12.68 (4.21;25.76) 9.15 (6.21;14.02) 0.163
TNFα 26.79 (11.72;45.42) 22.62 (15.81;46.91) 26.94 (12.11;33.99) 19.17 (11.64;28.8) 0.753
IFNα 69.0 (39.17;95.2) 62.96 (52.56;82.56) 71.14 (53.01;104.3) 69.01 (53.15;75.26) 0.742
EGF 158.5 (127.20;341.8) 165.0 (127.8;247.8) 245.5 (115.2;272.2) 188 (150.5;350) 0.932
VEGF 188 (114;427.8) 153 (111;274.2) 128 (80.45;293.8) 161 (132;390) 0.784
  1. No post hoc analysis was performed. EGF, epidermal growth factor; VEGF, vascular endothelial growth factor.
  2. P-value for Kruskal-Wallis test.